Association of smoking and alcohol use with rifampin-resistant TB treatment outcomes

被引：1
|
作者：
Campbell, J. R. [1 ,2 ,3 ,4 ]
Chen, E. D. [5 ,6 ,7 ]
Anderson, L. F. [8 ]
Bonnet, M. [9 ,10 ]
Brode, S. K. [11 ,12 ,13 ]
Cegielski, J. P. [14 ]
Guglielmetti, L. [15 ,16 ]
Singla, R. [17 ]
Fox, G. J. [18 ]
Skrahina, A. [19 ]
Rodrigues, D. [20 ]
Kuksa, L. [21 ]
Viiklepp, P. [22 ]
Menzies, D. [3 ,4 ,23 ]
机构：
[1] McGill Univ, Fac Med & Hlth Sci, Dept Med, Montreal, PQ, Canada
[2] McGill Univ, Fac Med & Hlth Sci, Dept Global & Publ Hlth, Montreal, PQ, Canada
[3] McGill Int TB Ctr, Montreal, PQ, Canada
[4] McGill Univ, Ctr Outcomes Res & Evaluat, Resp Epidemiol & Clin Res Unit, Res Inst,Hlth Ctr, Montreal, PQ, Canada
[5] Rocky Mt Reg Vet Affairs Med Ctr, Dept Med, Aurora, CO USA
[6] Natl Jewish Hlth, Dept Acad Affairs, Denver, CO USA
[7] Univ Colorado, Div Pulm Sci & Crit Care Med, Sch Med, Aurora, CO USA
[8] WHO, Global Malaria Programme, Strateg Informat Response, Geneva, Switzerland
[9] Univ Montpellier, Inst Rech Dev, INSERM, Rech Translat VIH & Malad Infect, Montpellier, France
[10] Epicentre, Paris, France
[11] West Pk Healthcare Ctr, Dept Resp Med, Toronto, ON, Canada
[12] Univ Hlth Network, Dept Med, Div Respirol, Toronto, ON, Canada
[13] Univ Toronto, Dept Med, Toronto, ON, Canada
[14] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA USA
[15] Sorbonne Univ, Ctr Immunol & Malad Infect Cimi Paris, INSERM, U1135, Paris, France
[16] Hop La Pitie Salpetriere, Assistance Publ Hop Paris, Lab Bacteriol Hyg, Ctr Natl Reference Mycobacteries & Resistance Myc, Paris, France
[17] Natl Inst TB & Resp Dis, Dept TB & Resp Dis, New Delhi, India
[18] Univ Sydney, Sydney, NSW, Australia
[19] Republican Res & Pract Ctr Pulmonol & TB, Minsk, BELARUS
[20] Inst Clemente Ferreira, Sao Paulo, SP, Brazil
[21] Riga East Univ Hosp, Dept MDR TB, Riga, Latvia
[22] Natl Inst Hlth Dev, Dept Registries, Tallinn, Estonia
[23] McGill Univ, Fac Med & Hlth Sci, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada
来源：
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE | 2023年 / 27卷 / 04期
关键词：
TUBERCULOSIS; PULMONARY;
D O I：
10.5588/ijtld.22.0678
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：338 / 340
页数：3
相关论文
共 37 条
  • [1] Association of indicators of extensive disease and rifampin-resistant tuberculosis treatment outcomes: an individual participant data meta-analysis
    Campbell, Jonathon R.
    Brode, Sarah K.
    Barry, Pennan
    Bastos, Mayara Lisboa
    Bonnet, Maryline
    Guglielmetti, Lorenzo
    Kempker, Russell
    Klimuk, Dzmitry
    Laborin, Rafael Laniado
    Milanov, Vladimir
    Singla, Rupak
    Skrahina, Alena
    Trajman, Anete
    van der Werf, Tjip S.
    Viiklepp, Piret
    Menzies, Dick
    THORAX, 2024, 79 (02) : 169 - 178
  • [2] Nationwide Treatment Outcomes of Patients With Multidrug/Rifampin-Resistant Tuberculosis in Korea, 2011-2017: A Retrospective Cohort Study (Korean TB-POST)
    Choi, Hongjo
    Mok, Jeongha
    Kang, Young Ae
    Jeong, Dawoon
    Kang, Hee-Yeon
    Kim, Hee Jin
    Kim, Hee-Sun
    Jeon, Doosoo
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2023, 38 (05)
  • [3] Timing and predictors of death during treatment in patients with multidrug/rifampin-resistant tuberculosis in South Korea
    Son, Eunjeong
    Choi, Hongjo
    Mok, Jeongha
    Kang, Young Ae
    Jeong, Dawoon
    Jeon, Doosoo
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2024, 39 (04) : 640 - 649
  • [4] Treatment outcomes of multidrug-resistant TB with selective use of new drugs
    Kwon, Y-S.
    Shin, J. E.
    Kang, H.
    Jeon, D.
    Yim, J-J.
    Shim, T. S.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2023, 27 (01) : 55 - +
  • [5] Implementation of Bedaquiline, Pretomanid, and Linezolid in the United States: Experience Using a Novel All-Oral Treatment Regimen for Treatment of Rifampin-Resistant or Rifampin-Intolerant Tuberculosis Disease
    Haley, Connie A.
    Schechter, Marcos C.
    Ashkin, David
    Peloquin, Charles A.
    Cegielski, J. Peter
    Andrino, Barbara B.
    Burgos, Marcos
    Caloia, Lori A.
    Chen, Lisa
    Colon-Semidey, Angel
    DeSilva, Malini B.
    Dhanireddy, Shireesha
    Dorman, Susan E.
    Dworkin, Felicia F.
    Hammond-Epstein, Heidi
    Easton, Alice, V
    Gaensbauer, James T.
    Ghassemieh, Bijan
    Gomez, Maria E.
    Horne, David
    Jasuja, Supriya
    Jones, Betsy A.
    Kaplan, Leonard J.
    Khan, Asharaf Edward
    Kracen, Elizabeth
    Labuda, Sarah
    Landers, Karen M.
    Lardizabal, Alfred A.
    Lasley, Maria T.
    Letzer, David M.
    Lopes, Vinicius K.
    Lubelchek, Ronald J.
    Macias, C. Patricia
    Mihalyov, Aimee
    Misch, Elizabeth Ann
    Murray, Jason A.
    Narita, Masahiro
    Nilsen, Diana M.
    Ninneman, Megan J.
    Ogawa, Lynne
    Oladele, Alawode
    Overman, Melissa
    Ray, Susan M.
    Ritger, Kathleen A.
    Rowlinson, Marie-Claire
    Sabuwala, Nadya
    Schiller, Thomas M.
    Schwartz, Lawrence E.
    Spitters, Christopher
    Thomson, Douglas B.
    CLINICAL INFECTIOUS DISEASES, 2023, 77 (07) : 1053 - 1062
  • [6] The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review
    Jürgen Rehm
    Andriy V Samokhvalov
    Manuela G Neuman
    Robin Room
    Charles Parry
    Knut Lönnroth
    Jayadeep Patra
    Vladimir Poznyak
    Svetlana Popova
    BMC Public Health, 9
  • [7] Improving outcomes for multidrug-resistant TB treatment
    Silva, D. R.
    De Queiroz Mello, F. C.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2022, 26 (02) : 93 - 95
  • [8] Treatment outcomes and safety in children with rifampicin-resistant TB
    Lopez-Varela, E.
    Garcia-Prats, A. J.
    Seddon, J. A.
    Draper, H. R.
    Winckler, J.
    van der Laan, L.
    Palmer, M.
    Burger, W. A.
    Schaaf, H. S.
    Hesseling, A. C.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2022, 26 (02) : 133 - +
  • [9] A host blood transcriptional signature differentiates multi-drug/rifampin-resistant tuberculosis (MDR/RR-TB) from drug susceptible tuberculosis: a pilot study
    Madamarandawala, Pavithra
    Rajapakse, Sanath
    Gunasena, Bandu
    Madegedara, Dushantha
    Magana-Arachchi, Dhammika
    MOLECULAR BIOLOGY REPORTS, 2023, 50 (04) : 3935 - 3943
  • [10] A host blood transcriptional signature differentiates multi-drug/rifampin-resistant tuberculosis (MDR/RR-TB) from drug susceptible tuberculosis: a pilot study
    Pavithra Madamarandawala
    Sanath Rajapakse
    Bandu Gunasena
    Dushantha Madegedara
    Dhammika Magana-Arachchi
    Molecular Biology Reports, 2023, 50 : 3935 - 3943
1234